Header Logo

Connection

Susan Zweizig to Humans

Back to Details
This is a "connection" page, showing publications Susan Zweizig has written about Humans.
Susan Zweizig
Connection Strength
0.136
Humans
  1. Zweizig S, Korets S, Cain JM. Key concepts in management of vulvar cancer. Best Pract Res Clin Obstet Gynaecol. 2014 Oct; 28(7):959-66.
    View in: PubMed
    Score: 0.018
  2. Brewer CA, Blessing JA, Nagourney RA, McMeekin DS, Lele S, Zweizig SL. Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol. 2006 Feb; 100(2):385-8.
    View in: PubMed
    Score: 0.010
  3. Herzog TJ, Liao JB, Finkelstein K, Willmott L, Duan W, Moroney JW, Buscema J, Campbell-Simms K, Yue Y, Zweizig S, Liu J, Wang X, Zang RY, Yin R, O'Malley DM, Wu L. An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044). Gynecol Oncol. 2025 Mar; 194:145-152.
    View in: PubMed
    Score: 0.009
  4. Klopp AH, Enserro D, Powell M, Randall M, Schink JC, Mannel RS, Holman L, Bender D, Kushnir CL, Backes F, Zweizig SL, Waggoner S, Bradley KA, Lawrence LD, Hanjani P, Darus CJ, Small W, Cardenes HR, Feddock JM, Miller DS. Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial. J Clin Oncol. 2024 Jul 10; 42(20):2425-2435.
    View in: PubMed
    Score: 0.009
  5. Zweizig SL. Cancer of the kidney. Clin Obstet Gynecol. 2002 Sep; 45(3):884-91.
    View in: PubMed
    Score: 0.008
  6. Miller DS, Filiaci VL, Mannel RS, Cohn DE, Matsumoto T, Tewari KS, DiSilvestro P, Pearl ML, Argenta PA, Powell MA, Zweizig SL, Warshal DP, Hanjani P, Carney ME, Huang H, Cella D, Zaino R, Fleming GF. Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209). J Clin Oncol. 2020 11 20; 38(33):3841-3850.
    View in: PubMed
    Score: 0.007
  7. Krill L, Deng W, Eskander R, Mutch D, Zweizig S, Hoang B, Ioffe O, Randall L, Lankes H, Miller DS, Birrer M. Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol. 2020 02; 156(2):423-429.
    View in: PubMed
    Score: 0.006
  8. Zweizig SL. Office screening for gynecologic cancer. Clin Obstet Gynecol. 1999 Jun; 42(2):267-75.
    View in: PubMed
    Score: 0.006
  9. Bishop EA, Java JJ, Moore KN, Spirtos NM, Pearl ML, Zivanovic O, Kushner DM, Backes F, Hamilton CA, Geller MA, Hurteau J, Mathews C, Wenham RM, Ramirez PT, Zweizig S, Walker JL. Surgical outcomes among elderly women with endometrial cancer?treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study. Am J Obstet Gynecol. 2018 01; 218(1):109.e1-109.e11.
    View in: PubMed
    Score: 0.006
  10. Devor EJ, Miecznikowski J, Schickling BM, Gonzalez-Bosquet J, Lankes HA, Thaker P, Argenta PA, Pearl ML, Zweizig SL, Mannel RS, Brown A, Ramirez NC, Ioffe OB, Park KJ, Creasman WT, Birrer MJ, Mutch D, Leslie KK. Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 12; 147(3):648-653.
    View in: PubMed
    Score: 0.006
  11. Zweizig S, Noller K, Reale F, Collis S, Resseguie L. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol Oncol. 1997 May; 65(2):314-8.
    View in: PubMed
    Score: 0.005
  12. Myers AP, Filiaci VL, Zhang Y, Pearl M, Behbakht K, Makker V, Hanjani P, Zweizig S, Burke JJ, Downey G, Leslie KK, Van Hummelen P, Birrer MJ, Fleming GF. Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2016 Apr; 141(1):43-8.
    View in: PubMed
    Score: 0.005
  13. Kandadai P, Flynn M, Zweizig S, Patterson D. Cost-utility of routine endometrial evaluation before le fort colpocleisis. Female Pelvic Med Reconstr Surg. 2014 May-Jun; 20(3):168-73.
    View in: PubMed
    Score: 0.004
  14. Zweizig S, Roman LD, Muderspach LI. Death from anaphylaxis to cisplatin: a case report. Gynecol Oncol. 1994 Apr; 53(1):121-2.
    View in: PubMed
    Score: 0.004
  15. Fleming GF, Filiaci VL, Marzullo B, Zaino RJ, Davidson SA, Pearl M, Makker V, Burke JJ, Zweizig SL, Van Le L, Hanjani P, Downey G, Walker JL, Reyes HD, Leslie KK. Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study. Gynecol Oncol. 2014 Mar; 132(3):585-92.
    View in: PubMed
    Score: 0.004
  16. Zweizig S, Perron J, Grubb D, Mishell DR. Conservative management of adnexal torsion. Am J Obstet Gynecol. 1993 Jun; 168(6 Pt 1):1791-5.
    View in: PubMed
    Score: 0.004
  17. Hughes S, Leary A, Zweizig S, Cain J. Surgery in elderly people: preoperative, operative and postoperative care to assist healing. Best Pract Res Clin Obstet Gynaecol. 2013 Oct; 27(5):753-65.
    View in: PubMed
    Score: 0.004
  18. Mailhot J, O'Donnell P, Han R, Zweizig S, Geist DE. Metastatic squamous cell carcinoma of the vulva mimicking primary varicella-zoster virus infection. J Am Acad Dermatol. 2011 Aug; 65(2):e63-e64.
    View in: PubMed
    Score: 0.004
  19. Zweizig S, Schlaerth JB, Boswell WD. Computed tomography of lymphogranuloma venereum mimicking cervical cancer. Comput Med Imaging Graph. 1991 Mar-Apr; 15(2):97-100.
    View in: PubMed
    Score: 0.004
  20. De Geest K, Blessing JA, Morris RT, Yamada SD, Monk BJ, Zweizig SL, Matei D, Muller CY, Richards WE. Phase II clinical trial of ixabepilone in patients with recurrent or persistent platinum- and taxane-resistant ovarian or primary peritoneal cancer: a gynecologic oncology group study. J Clin Oncol. 2010 Jan 01; 28(1):149-53.
    View in: PubMed
    Score: 0.003
  21. Quesenberry CD, Li C, Chen AH, Zweizig SL, Ball HG. Primary angiosarcoma of the ovary: a case report of Stage I disease. Gynecol Oncol. 2005 Oct; 99(1):218-21.
    View in: PubMed
    Score: 0.002
  22. Attanucci CA, Ball HG, Zweizig SL, Chen AH. Differences in symptoms between patients with benign and malignant ovarian neoplasms. Am J Obstet Gynecol. 2004 May; 190(5):1435-7.
    View in: PubMed
    Score: 0.002
  23. Chavez NF, Zweizig SL, Stewart EA. Neuropathic uterine pain after hysterectomy. A case report. J Reprod Med. 2003 Jun; 48(6):466-8.
    View in: PubMed
    Score: 0.002
  24. Simkin PH, Ramirez LA, Zweizig SL, Afonso SA, Fraire AE, Khan A, Dunn AD, Dunn JT, Braverman LE. Monomorphic teratoma of the ovary: a rare cause of triiodothyronine toxicosis. Thyroid. 1999 Sep; 9(9):949-54.
    View in: PubMed
    Score: 0.002
  25. Zheng J, Wan M, Zweizig S, Velicescu M, Yu MC, Dubeau L. Histologically benign or low-grade malignant tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas. Cancer Res. 1993 Sep 15; 53(18):4138-42.
    View in: PubMed
    Score: 0.001
  26. Dubuc-Lissoir J, Zweizig S, Sweizig S, Schlaerth JB, Morrow CP. Metastatic gestational trophoblastic disease: a comparison of prognostic classification systems. Gynecol Oncol. 1992 Apr; 45(1):40-5.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.